Found 37 matching trials
Autologous Polyclonal Tregs for Lupus
PHASE1The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Location
University of California, San Francisco
RAPA-501 Therapy of ALS Expanded Access Protocol
N/ARAPA-501-ALS is an Intermediate-Size Expanded Access Trial of RAPA-501 auto...
Status
Temporarily Not Available
Location
Barrow Neurological Institute
Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease
PHASE2The investigational product, named Ovasave (Ova-Treg), is a cell-based ther...
Location
Medical University Innsbruck
Safety and Efficacy Study of Islets Xenotransplantation
NAThe neonatal pig islets will be used as donor culturing with our modified c...
Location
Cell Transplantation and Gene Therapy Institute
Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients
PHASE1The purpose of this study is to evaluate the safety and tolerability of QEL...
Status
Active Not Recruiting
T-regulatory Cells in ALS
PHASE2This study is a randomized, placebo-controlled, phase 2a trial to study the...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Neurological Clinical Research Institute
DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
PHASE2Patients with newly diagnosed glioblastoma will be consented following tumo...
Status
Active Not Recruiting
Location
Duke University Medical Center
The ONE Study UK Treg Trial
PHASE1A study to assess cell therapy as a treatment to prevent kidney transplant ...
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
PHASE1The purpose of this study is look at the safety of:
* Taking a specific co...
Location
University of California, San Francisco
Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases
PHASE1An open, multi- center phase Ⅰ clinical study evaluating the safety and eff...
Location
The First Affiliated Hospital of Zhengzhou University